数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Sarah M. London Chief Executive Officer,Director 43 1324.64万美元 9.64 2024-01-01
Theodore R. Samuels Independent Director 69 71.12万美元 2.29 2024-01-01
Jessica L. Blume Independent Director 69 34.47万美元 1.89 2024-01-01
Kenneth A. Burdick Director 65 178.45万美元 43.93 2024-01-01
Lori J. Robinson Independent Director 65 29.71万美元 0.85 2024-01-01
Frederick H. Eppinger Independent Director 65 35.94万美元 17.12 2024-01-01
Christopher J. Coughlin Independent Director 71 73.12万美元 1.72 2024-01-01
Wayne S. DeVeydt Independent Director 54 71.41万美元 0.49 2024-01-01
H. James Dallas Chairman of the Board,Independent Director 65 43.79万美元 2.84 2024-01-01
Monte E. Ford Independent Director 64 46.75万美元 0.14 2024-01-01

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
David P. Thomas Chief Executive Officer of Markets and Medicaid 58 463.38万美元 4.75 2024-01-01
Sarah M. London Chief Executive Officer,Director 43 1324.64万美元 9.64 2024-01-01
Andrew L. Asher Executive Vice President, Chief Financial Officer 55 973.92万美元 19.28 2024-01-01
Christopher A. Koster Executive Vice President, Secretary and General Counsel 59 242.25万美元 9.29 2024-01-01
Katie N. Casso Senior Vice President, Corporate Controller & Chief Accounting Officer 42 未披露 未持股 2024-01-01
Kenneth J. Fasola President 64 998.27万美元 5.53 2024-01-01
Susan Smith Chief Operating Officer 48 未披露 未持股 2024-01-01

董事简历

中英对照 |  中文 |  英文
Sarah M. London

Sarah M. London自2020年9月起担任Centene Corporation的高级副总裁,技术和现代化。在加入Centene Corporation之前,她曾于2018年5月至2020年3月担任Optum Ventures的高级负责人和合伙人,2016年3月至2018年5月担任Optum的首席产品官。2014年3月至2016年3月,她担任Humedica的客户管理和运营部副总裁。


Sarah M. London,has served as Centene Corporation Chief Executive Officer since March 2022. From September 2021 to March 2022, she served as Vice Chairman. She served as President, Centene Health Care Enterprises and Executive Vice President, Advanced Technology from March 2021 to September 2021. From September 2020 to February 2021, she served as Senior Vice President, Technology Innovation and Modernization. Prior to joining Centene, she served as both Senior Principal and Partner for Optum Ventures from May 2018 to March 2020 and Chief Product Officer of Optum from March 2016 to May 2018.
Sarah M. London自2020年9月起担任Centene Corporation的高级副总裁,技术和现代化。在加入Centene Corporation之前,她曾于2018年5月至2020年3月担任Optum Ventures的高级负责人和合伙人,2016年3月至2018年5月担任Optum的首席产品官。2014年3月至2016年3月,她担任Humedica的客户管理和运营部副总裁。
Sarah M. London,has served as Centene Corporation Chief Executive Officer since March 2022. From September 2021 to March 2022, she served as Vice Chairman. She served as President, Centene Health Care Enterprises and Executive Vice President, Advanced Technology from March 2021 to September 2021. From September 2020 to February 2021, she served as Senior Vice President, Technology Innovation and Modernization. Prior to joining Centene, she served as both Senior Principal and Partner for Optum Ventures from May 2018 to March 2020 and Chief Product Officer of Optum from March 2016 to May 2018.
Theodore R. Samuels

Theodore R. Samuels,曾任职Capital Group Companies(1981年至2016年)。他曾担任 the Capital Guardian Trust Company的总裁(2010年至2016年),也曾担任资本集团代表,专注于长期投资(从2014年到2015年)。他曾担任投资组合经理(从1990年到2016年),期间任职Capital Group的多种管理和投资委员会。他也曾担任Capital Group Foundation的董事会成员,以及Capital Group Foundation Investment Committee和the Capital International North America Proxy Committee的主席。他曾任职于the Capital Group Finance Committee(2013年至2016年),此前曾任职于the Capital Group Board和the Capital Group Audit Committee。他也担任Tuft''s President''s Council、the Harvard West Cost Council的联席主席,也是the Harvard College Fund Executive Committee的成员。他是Children''s Hospital Los Angeles的受托人,在那里他曾担任联席主席(2012年至2015年),也是the Pasadena City College Foundation的受托人。


Theodore R. Samuels,Former President of Capital Guardian Trust Company and a former global equity portfolio manager at Capital Group, one of the most prominent investment management organizations in the world.While at Capital Group he served on numerous management and investment committees, with an eye towards long-term shareholder value creation.Received a Bachelor of Arts from Harvard College and a Master of Business Administration from Harvard Business School.
Theodore R. Samuels,曾任职Capital Group Companies(1981年至2016年)。他曾担任 the Capital Guardian Trust Company的总裁(2010年至2016年),也曾担任资本集团代表,专注于长期投资(从2014年到2015年)。他曾担任投资组合经理(从1990年到2016年),期间任职Capital Group的多种管理和投资委员会。他也曾担任Capital Group Foundation的董事会成员,以及Capital Group Foundation Investment Committee和the Capital International North America Proxy Committee的主席。他曾任职于the Capital Group Finance Committee(2013年至2016年),此前曾任职于the Capital Group Board和the Capital Group Audit Committee。他也担任Tuft''s President''s Council、the Harvard West Cost Council的联席主席,也是the Harvard College Fund Executive Committee的成员。他是Children''s Hospital Los Angeles的受托人,在那里他曾担任联席主席(2012年至2015年),也是the Pasadena City College Foundation的受托人。
Theodore R. Samuels,Former President of Capital Guardian Trust Company and a former global equity portfolio manager at Capital Group, one of the most prominent investment management organizations in the world.While at Capital Group he served on numerous management and investment committees, with an eye towards long-term shareholder value creation.Received a Bachelor of Arts from Harvard College and a Master of Business Administration from Harvard Business School.
Jessica L. Blume

Jessica L. Blume,从2012年开始担任德勤(Deloitte LLP)的副董事长,直到2015年退休。在德勤(Deloitte)的26年间,她担任过各种领导职务,包括在董事会任职,执行薪酬和评估委员会主席,以及 财务,治理,战略投资和风险委员会的成员。 Blume女士目前担任Publix Super Markets,Inc.的董事。


Jessica L. Blume,Vice Chairman of Deloitte LLP from 2012 until her retirement in 2015.Served in various leadership positions during her 26 years at Deloitte including serving on the firm's US Executive Committee and Board of Directors, as the Chair of the Executive Compensation and Evaluation Committee, as a member of the Finance, Governance, Strategic Investment and Risk Committees and established and managed Deloitte's ESG practice. Prior to Deloitte, she served as a CFO for one of the largest US local governments. Received a Bachelor of Science from the University of Central Florida and is a CPA.
Jessica L. Blume,从2012年开始担任德勤(Deloitte LLP)的副董事长,直到2015年退休。在德勤(Deloitte)的26年间,她担任过各种领导职务,包括在董事会任职,执行薪酬和评估委员会主席,以及 财务,治理,战略投资和风险委员会的成员。 Blume女士目前担任Publix Super Markets,Inc.的董事。
Jessica L. Blume,Vice Chairman of Deloitte LLP from 2012 until her retirement in 2015.Served in various leadership positions during her 26 years at Deloitte including serving on the firm's US Executive Committee and Board of Directors, as the Chair of the Executive Compensation and Evaluation Committee, as a member of the Finance, Governance, Strategic Investment and Risk Committees and established and managed Deloitte's ESG practice. Prior to Deloitte, she served as a CFO for one of the largest US local governments. Received a Bachelor of Science from the University of Central Florida and is a CPA.
Kenneth A. Burdick

Kenneth A. Burdick于2020年1月23日起担任Centene Corporation市场与产品执行副总裁,至2021年2月21日退休。2015年起担任WellCare Health计划公司首席执行官,直至2020年1月公司被Centene收购。Burdick先生于2014年加入WellCare,最初担任National Health计划总裁,后担任总裁兼首席运营官。2012年2月至2012年7月,他担任Blue Cross and Blue Shield of Minnesota总裁兼首席执行官。2010年8月至2012年2月,他担任Coventry Health Care,Inc.医疗补助和行为健康业务的首席执行官。1995年10月至2009年5月,Burdick先生在UnitedHealth Group,Inc.担任多个职位,包括2006年至2008年担任UnitedHealthcare首席执行官,2008年至2009年担任UnitedHealthcare Secured Horizons Medicare部门首席执行官。Burdick先生目前在Orion Acquisition公司和第一地平线国家公司董事会任职。他目前还在Big Brothers Big Sisters of America的董事会任职,自2017年起担任Big Brothers Big Sisters of America董事会成员,包括自2018年7月起担任国家董事会主席。


Kenneth A. Burdick,CEO and Chairman of Lifestance Health, Inc., a Nasdaq listed public company specializing in behavioral health, beginning in September 2022.Executive Vice President of Markets and Products of Centene Corporation from January 23, 2020, until his retirement on February 21, 2021.Chief Executive Officer of WellCare Health Plans, Inc. from 2015 until January 2020, when the company was acquired by Centene.Joined WellCare in 2014, serving initially as President, National Health Plans and then as President and Chief Operating Officer.President and Chief Executive Officer of Blue Cross and Blue Shield of Minnesota from February 2012 to July 2012.Chief Executive Officer of the Medicaid and Behavioral Health businesses of Coventry Health Care, Inc. from August 2010 to February 2012.Held a variety of positions with UnitedHealth Group, Inc., including Chief Executive Officer of UnitedHealthcare from 2006 to 2008 and Chief Executive Officer of Secured Horizons (Medicare division of UnitedHealthcare) from 2008 to 2009.Received a Bachelor of Arts from Amherst College and a Juris Doctorate from the University of Connecticut.
Kenneth A. Burdick于2020年1月23日起担任Centene Corporation市场与产品执行副总裁,至2021年2月21日退休。2015年起担任WellCare Health计划公司首席执行官,直至2020年1月公司被Centene收购。Burdick先生于2014年加入WellCare,最初担任National Health计划总裁,后担任总裁兼首席运营官。2012年2月至2012年7月,他担任Blue Cross and Blue Shield of Minnesota总裁兼首席执行官。2010年8月至2012年2月,他担任Coventry Health Care,Inc.医疗补助和行为健康业务的首席执行官。1995年10月至2009年5月,Burdick先生在UnitedHealth Group,Inc.担任多个职位,包括2006年至2008年担任UnitedHealthcare首席执行官,2008年至2009年担任UnitedHealthcare Secured Horizons Medicare部门首席执行官。Burdick先生目前在Orion Acquisition公司和第一地平线国家公司董事会任职。他目前还在Big Brothers Big Sisters of America的董事会任职,自2017年起担任Big Brothers Big Sisters of America董事会成员,包括自2018年7月起担任国家董事会主席。
Kenneth A. Burdick,CEO and Chairman of Lifestance Health, Inc., a Nasdaq listed public company specializing in behavioral health, beginning in September 2022.Executive Vice President of Markets and Products of Centene Corporation from January 23, 2020, until his retirement on February 21, 2021.Chief Executive Officer of WellCare Health Plans, Inc. from 2015 until January 2020, when the company was acquired by Centene.Joined WellCare in 2014, serving initially as President, National Health Plans and then as President and Chief Operating Officer.President and Chief Executive Officer of Blue Cross and Blue Shield of Minnesota from February 2012 to July 2012.Chief Executive Officer of the Medicaid and Behavioral Health businesses of Coventry Health Care, Inc. from August 2010 to February 2012.Held a variety of positions with UnitedHealth Group, Inc., including Chief Executive Officer of UnitedHealthcare from 2006 to 2008 and Chief Executive Officer of Secured Horizons (Medicare division of UnitedHealthcare) from 2008 to 2009.Received a Bachelor of Arts from Amherst College and a Juris Doctorate from the University of Connecticut.
Lori J. Robinson

Lori J. Robinson在空军服役直至2018年7月退休,此前她从事了36年的军事生涯,其中包括北美航空航天防御司令部NORAD司令和美国北方司令部NORTHCOM。 Robinson将军目前担任科恩·费里(Korn Ferry)和NACCO的董事会成员。


Lori J. Robinson,Non-Resident Senior Fellow (2018 – Present),Harvard Kennedy School, Belfer Center for Science and International Affairs;Founder, Director (2018 – Present),The Robinson Group, LLC;Commander (2016 – 2018),U.S. Northern Command and North American Aerospace Defense Command, Department of Defense;Commander (2014 – 2016),Pacific Air Forces, U.S. Air Force;Vice Commander (2013 – 2014),Air Combat Command, U.S. Air Force.
Lori J. Robinson在空军服役直至2018年7月退休,此前她从事了36年的军事生涯,其中包括北美航空航天防御司令部NORAD司令和美国北方司令部NORTHCOM。 Robinson将军目前担任科恩·费里(Korn Ferry)和NACCO的董事会成员。
Lori J. Robinson,Non-Resident Senior Fellow (2018 – Present),Harvard Kennedy School, Belfer Center for Science and International Affairs;Founder, Director (2018 – Present),The Robinson Group, LLC;Commander (2016 – 2018),U.S. Northern Command and North American Aerospace Defense Command, Department of Defense;Commander (2014 – 2016),Pacific Air Forces, U.S. Air Force;Vice Commander (2013 – 2014),Air Combat Command, U.S. Air Force.
Frederick H. Eppinger

Frederick H. Eppinger自2006年4月以来担任董事。他自2003年以来担任The Hanover Insurance Group, Inc.(保险公司某一集团的控股公司,提供广泛的财产保险产品)的董事、总裁兼首席执行官。从2001年到2003年他是The Hartford Financial Services Group, Inc.财产保险领域和服务业务的执行副总裁。从2000年到2001年他是Channel Point, Inc.的执行副总裁。从1985年到2000年他在McKinsey & Company(国际管理咨询公司)的金融机构集团工作,在那里他在1992年被承认是合伙人。他的经验包括,特别是担任首席执行官以及组织发展和保险行业专业知识。


Frederick H. Eppinger,Chief Executive Officer since 2019 and a Director since 2016 of Stewart Information Services Company.Director, President and Chief Executive Officer of The Hanover Insurance Group, Inc. (insurance and financial services industries) from 2003 to 2016.Senior Partner at McKinsey & Co. from 1985 to 2000.Served as a director of QBE Insurance Group Limited.Received a Bachelor of Arts from the College of the Holy Cross and a Master of Business Administration from the Tuck School of Business Administration at Dartmouth College.
Frederick H. Eppinger自2006年4月以来担任董事。他自2003年以来担任The Hanover Insurance Group, Inc.(保险公司某一集团的控股公司,提供广泛的财产保险产品)的董事、总裁兼首席执行官。从2001年到2003年他是The Hartford Financial Services Group, Inc.财产保险领域和服务业务的执行副总裁。从2000年到2001年他是Channel Point, Inc.的执行副总裁。从1985年到2000年他在McKinsey & Company(国际管理咨询公司)的金融机构集团工作,在那里他在1992年被承认是合伙人。他的经验包括,特别是担任首席执行官以及组织发展和保险行业专业知识。
Frederick H. Eppinger,Chief Executive Officer since 2019 and a Director since 2016 of Stewart Information Services Company.Director, President and Chief Executive Officer of The Hanover Insurance Group, Inc. (insurance and financial services industries) from 2003 to 2016.Senior Partner at McKinsey & Co. from 1985 to 2000.Served as a director of QBE Insurance Group Limited.Received a Bachelor of Arts from the College of the Holy Cross and a Master of Business Administration from the Tuck School of Business Administration at Dartmouth College.
Christopher J. Coughlin

Christopher J. Coughlin,自2004年12月担任邓白氏董事会的主任,事务委员会的主席和薪酬福利委员会的成员。2010年8月至2013年10月他还担任董事会的主席。从2005年3月至2010年12月他担任一家消防和安全解决方案的全球领先者,泰科国际有限公司的执行副总裁和首席财务官,从2010年12月到2012年10月担任公司顾问。此前,从2003年6月到2004年12月他担任Interpublic集团股份有限公司的执行副总裁和首席运营官,从2003年8月至2004年6月作为首席财务官,从2003年7月到2004年7月担任总裁。在这之前,从1998年到2003年他担任法玛西亚公司的执行副总裁和首席财务官,在他担任执行副总裁之前,担任纳贝斯克国际一个部门的总裁。他目前担任麦肯锡公司的一位高级顾问,也是以下公共公司董事:Covidien有限责任公司, Forest实验室股份有限公司和Dipexium 制药股份有限公司,他在过去五年中没有担任任何其他公共公司的董事。他曾担任Perrigo公司,Monsanto公司和Interpublic公司集团股份有限公司的董事。


Christopher J. Coughlin,Senior Advisor to the CEO and Board of Directors of Tyco International from 2010 to his retirement in 2012.Executive Vice President and CFO of Tyco from 2005 to 2010, during which he was instrumental in turning the company around after a management and financial scandal and ultimately separated it into six separate public companies.Chief Operating Officer of the Interpublic Group of Companies from June 2003 to December 2004 and as Chief Financial Officer from August 2003 to June 2004.Executive Vice President and Chief Financial Officer of Pharmacia Corporation from 1998 until its acquisition by Pfizer in 2003.Named a 2022 Director of the Year by the New Jersey Chapter of the National Association of Corporate Directors (NACD) for his leadership in public corporate governance.Named the NACD Corporate Director of the Year in 2015.Received a Bachelor of Science from Boston College.
Christopher J. Coughlin,自2004年12月担任邓白氏董事会的主任,事务委员会的主席和薪酬福利委员会的成员。2010年8月至2013年10月他还担任董事会的主席。从2005年3月至2010年12月他担任一家消防和安全解决方案的全球领先者,泰科国际有限公司的执行副总裁和首席财务官,从2010年12月到2012年10月担任公司顾问。此前,从2003年6月到2004年12月他担任Interpublic集团股份有限公司的执行副总裁和首席运营官,从2003年8月至2004年6月作为首席财务官,从2003年7月到2004年7月担任总裁。在这之前,从1998年到2003年他担任法玛西亚公司的执行副总裁和首席财务官,在他担任执行副总裁之前,担任纳贝斯克国际一个部门的总裁。他目前担任麦肯锡公司的一位高级顾问,也是以下公共公司董事:Covidien有限责任公司, Forest实验室股份有限公司和Dipexium 制药股份有限公司,他在过去五年中没有担任任何其他公共公司的董事。他曾担任Perrigo公司,Monsanto公司和Interpublic公司集团股份有限公司的董事。
Christopher J. Coughlin,Senior Advisor to the CEO and Board of Directors of Tyco International from 2010 to his retirement in 2012.Executive Vice President and CFO of Tyco from 2005 to 2010, during which he was instrumental in turning the company around after a management and financial scandal and ultimately separated it into six separate public companies.Chief Operating Officer of the Interpublic Group of Companies from June 2003 to December 2004 and as Chief Financial Officer from August 2003 to June 2004.Executive Vice President and Chief Financial Officer of Pharmacia Corporation from 1998 until its acquisition by Pfizer in 2003.Named a 2022 Director of the Year by the New Jersey Chapter of the National Association of Corporate Directors (NACD) for his leadership in public corporate governance.Named the NACD Corporate Director of the Year in 2015.Received a Bachelor of Science from Boston College.
Wayne S. DeVeydt

Wayne S. DeVeydt自2020年1月起担任医疗保健服务公司Surgery Partners, Inc.的董事会执行主席。在此之前,他于2018年1月至2020年1月担任Surgery Partners的首席执行官兼董事会成员。在加盟Surgery Partners, Inc.之前,他曾于2017年1月至2018年1月在全球多元资产另类资产公司Bain Capital资本全球医疗保健部门担任高级顾问,于2007年5月在健康保险公司Anthem, Inc.担任执行副总裁兼CFO,Anthem, Inc.是Blue Cross and Blue Shield Association的独立持牌人,至2016年6月退休。他还于2005年开始担任Anthem公司高级副总裁兼首席会计干事,并于2006年至2007年担任董事长兼首席执行官的办公室主任。在加入Anthem, Inc.之前,DeVeydt先生于1996年至2005年期间担任普华永道会计师事务所的合伙人,在金融服务行业担任过许多职务。DeVeydt先生是Surgery Partners, Inc.的董事会成员,目前担任Surgery Partners, Inc.的执行主席。2016年12月至2019年12月,他担任Grupo Notre Dame Intermedica董事会成员,并担任审计委员会主席。2016年至2018年7月,他还担任Myovant Sciences董事,并担任公司首席独立董事、审计委员会主席、薪酬委员会成员。DeVeydt先生通过他的慈善活动在他的社区中是一个积极的领导者。


Wayne S. DeVeydt,Managing Director at Bain Capital since March 2022.Executive Chairman of the Board of Directors of Surgery Partners, Inc. since January of 2020.Chief Executive Officer and Director of Surgery Partners, Inc. from January 2018 until January 2020.Senior Advisor to the Global Healthcare division of Bain Capital Private Equity, LP from January 2017 until January 2018.Executive Vice President and Chief Financial Officer of Anthem, Inc. for nearly a decade.During his tenure at Anthem, he also held numerous other leadership roles, including Chief Strategy Officer, Chief Accounting Officer, and Chief of Staff to the Chairman and Chief Executive Officer.Previously a partner with PricewaterhouseCoopers, where he served the managed care and healthcare sector.Receive a Bachelor of Science in Accounting from the University of Missouri.
Wayne S. DeVeydt自2020年1月起担任医疗保健服务公司Surgery Partners, Inc.的董事会执行主席。在此之前,他于2018年1月至2020年1月担任Surgery Partners的首席执行官兼董事会成员。在加盟Surgery Partners, Inc.之前,他曾于2017年1月至2018年1月在全球多元资产另类资产公司Bain Capital资本全球医疗保健部门担任高级顾问,于2007年5月在健康保险公司Anthem, Inc.担任执行副总裁兼CFO,Anthem, Inc.是Blue Cross and Blue Shield Association的独立持牌人,至2016年6月退休。他还于2005年开始担任Anthem公司高级副总裁兼首席会计干事,并于2006年至2007年担任董事长兼首席执行官的办公室主任。在加入Anthem, Inc.之前,DeVeydt先生于1996年至2005年期间担任普华永道会计师事务所的合伙人,在金融服务行业担任过许多职务。DeVeydt先生是Surgery Partners, Inc.的董事会成员,目前担任Surgery Partners, Inc.的执行主席。2016年12月至2019年12月,他担任Grupo Notre Dame Intermedica董事会成员,并担任审计委员会主席。2016年至2018年7月,他还担任Myovant Sciences董事,并担任公司首席独立董事、审计委员会主席、薪酬委员会成员。DeVeydt先生通过他的慈善活动在他的社区中是一个积极的领导者。
Wayne S. DeVeydt,Managing Director at Bain Capital since March 2022.Executive Chairman of the Board of Directors of Surgery Partners, Inc. since January of 2020.Chief Executive Officer and Director of Surgery Partners, Inc. from January 2018 until January 2020.Senior Advisor to the Global Healthcare division of Bain Capital Private Equity, LP from January 2017 until January 2018.Executive Vice President and Chief Financial Officer of Anthem, Inc. for nearly a decade.During his tenure at Anthem, he also held numerous other leadership roles, including Chief Strategy Officer, Chief Accounting Officer, and Chief of Staff to the Chairman and Chief Executive Officer.Previously a partner with PricewaterhouseCoopers, where he served the managed care and healthcare sector.Receive a Bachelor of Science in Accounting from the University of Missouri.
H. James Dallas

H. James Dallas,他于2013年从Medtronic公司退休。退休时担任该公司高级副总裁,负责质量和运营事务。Medtronic公司是一家全球医学技术公司,拥有约46000名员工,其业务拓展到了140多个国家。他于2006年加盟Medtronic公司。他曾在Medtronic公司担任高级副总裁和首席信息官。他的职责范围包括实施跨业务的行动以将公司的全球经营杠杆增至最大限度。他还是Medtronic公司的高级管理团队成员。


H. James Dallas,In 2013, Mr. Dallas retired as Senior Vice President of Quality and Operations at Medtronic Inc., a global medical technology company. Mr. Dallas, who joined Medtronic Inc. in 2006, had previously served as Senior Vice President and Chief Information Officer at Medtronic Inc. Mr. Dallas's responsibilities included executing cross-business initiatives to maximize the company's global operating leveraging. Mr. Dallas also served as a member of Medtronic Inc.'s executive management team. Mr. Dallas is an independent consultant focusing on change management, information technology strategy, and risk. He also serves as a director of Grady Memorial Hospital Corporation.
H. James Dallas,他于2013年从Medtronic公司退休。退休时担任该公司高级副总裁,负责质量和运营事务。Medtronic公司是一家全球医学技术公司,拥有约46000名员工,其业务拓展到了140多个国家。他于2006年加盟Medtronic公司。他曾在Medtronic公司担任高级副总裁和首席信息官。他的职责范围包括实施跨业务的行动以将公司的全球经营杠杆增至最大限度。他还是Medtronic公司的高级管理团队成员。
H. James Dallas,In 2013, Mr. Dallas retired as Senior Vice President of Quality and Operations at Medtronic Inc., a global medical technology company. Mr. Dallas, who joined Medtronic Inc. in 2006, had previously served as Senior Vice President and Chief Information Officer at Medtronic Inc. Mr. Dallas's responsibilities included executing cross-business initiatives to maximize the company's global operating leveraging. Mr. Dallas also served as a member of Medtronic Inc.'s executive management team. Mr. Dallas is an independent consultant focusing on change management, information technology strategy, and risk. He also serves as a director of Grady Memorial Hospital Corporation.
Monte E. Ford

Monte E. Ford, 目前是the CIO Strategy Exchange(前50名首席信息官商业组织)的首席合伙人。他也担任Brightwood Capital Advisors(提供增长资本中间市场的业务)的合作合伙人。从2012年2月到2013年9月,他担任Aptean Software Corporation(企业应用系统整合软件的供应商)的首席执行官。加入Aptean之前,他曾担任American Airlines, Inc.的高级副总裁兼首席信息官(从2000年12月到2011年12月)。他是Akamai Technologies, Inc.(领先的互联网网络安全公司)的董事会成员,在那里他任职于薪酬和提名和公司治理委员会。


Monte E. Ford,Principal Partner of CIO Strategy Exchange, a membership organization for chief information officers, since 2016.Network Partner at Brightwood Capital Partners, a venture capital firm, since 2013.Iron Mountain Incorporated, a provider of storage and other information management services.JetBlue Airways Corporation, an airline.The Michaels Companies, an arts and crafts retailer.
Monte E. Ford, 目前是the CIO Strategy Exchange(前50名首席信息官商业组织)的首席合伙人。他也担任Brightwood Capital Advisors(提供增长资本中间市场的业务)的合作合伙人。从2012年2月到2013年9月,他担任Aptean Software Corporation(企业应用系统整合软件的供应商)的首席执行官。加入Aptean之前,他曾担任American Airlines, Inc.的高级副总裁兼首席信息官(从2000年12月到2011年12月)。他是Akamai Technologies, Inc.(领先的互联网网络安全公司)的董事会成员,在那里他任职于薪酬和提名和公司治理委员会。
Monte E. Ford,Principal Partner of CIO Strategy Exchange, a membership organization for chief information officers, since 2016.Network Partner at Brightwood Capital Partners, a venture capital firm, since 2013.Iron Mountain Incorporated, a provider of storage and other information management services.JetBlue Airways Corporation, an airline.The Michaels Companies, an arts and crafts retailer.

高管简历

中英对照 |  中文 |  英文
David P. Thomas

David P. Thomas自2019年10月起担任Centene公司市场执行副总裁。2019年1月至2019年10月,他担任Fidelis Care的总裁兼首席执行官。2018年5月至2018年12月,他担任Fidelis Care总裁。他还曾于2012年1月至2018年4月担任Fidelis Care的首席运营官。


David P. Thomas has served as Centene Corporation's Executive Vice President of Markets since October 2019. From January 2019 through October 2019 he served as President and Chief Executive Officer of Fidelis Care. From May 2018 to December 2018 he served as President of Fidelis Care. He also previously served as Chief Operating Officer for Fidelis Care from January 2012 through April 2018.
David P. Thomas自2019年10月起担任Centene公司市场执行副总裁。2019年1月至2019年10月,他担任Fidelis Care的总裁兼首席执行官。2018年5月至2018年12月,他担任Fidelis Care总裁。他还曾于2012年1月至2018年4月担任Fidelis Care的首席运营官。
David P. Thomas has served as Centene Corporation's Executive Vice President of Markets since October 2019. From January 2019 through October 2019 he served as President and Chief Executive Officer of Fidelis Care. From May 2018 to December 2018 he served as President of Fidelis Care. He also previously served as Chief Operating Officer for Fidelis Care from January 2012 through April 2018.
Sarah M. London

Sarah M. London自2020年9月起担任Centene Corporation的高级副总裁,技术和现代化。在加入Centene Corporation之前,她曾于2018年5月至2020年3月担任Optum Ventures的高级负责人和合伙人,2016年3月至2018年5月担任Optum的首席产品官。2014年3月至2016年3月,她担任Humedica的客户管理和运营部副总裁。


Sarah M. London,has served as Centene Corporation Chief Executive Officer since March 2022. From September 2021 to March 2022, she served as Vice Chairman. She served as President, Centene Health Care Enterprises and Executive Vice President, Advanced Technology from March 2021 to September 2021. From September 2020 to February 2021, she served as Senior Vice President, Technology Innovation and Modernization. Prior to joining Centene, she served as both Senior Principal and Partner for Optum Ventures from May 2018 to March 2020 and Chief Product Officer of Optum from March 2016 to May 2018.
Sarah M. London自2020年9月起担任Centene Corporation的高级副总裁,技术和现代化。在加入Centene Corporation之前,她曾于2018年5月至2020年3月担任Optum Ventures的高级负责人和合伙人,2016年3月至2018年5月担任Optum的首席产品官。2014年3月至2016年3月,她担任Humedica的客户管理和运营部副总裁。
Sarah M. London,has served as Centene Corporation Chief Executive Officer since March 2022. From September 2021 to March 2022, she served as Vice Chairman. She served as President, Centene Health Care Enterprises and Executive Vice President, Advanced Technology from March 2021 to September 2021. From September 2020 to February 2021, she served as Senior Vice President, Technology Innovation and Modernization. Prior to joining Centene, she served as both Senior Principal and Partner for Optum Ventures from May 2018 to March 2020 and Chief Product Officer of Optum from March 2016 to May 2018.
Andrew L. Asher

Andrew L. Asher自2014年11月起担任公司高级副总裁和首席财务官。他于2014年8月加入WellCare高级副总裁。他领导公司的财务活动,包括财务和绩效管理、资本战略和规划、会计、精算、医疗经济学、投资管理、企业发展和投资者关系。加入WellCare之前,Asher曾担任Aetna当地和区域业务首席财务官,自2013年5月起担任,当时正值他的前任雇主公司Coventry Health Care被Aetna收购。Asher在Coventry待了15年,最近的职位是担任企业金融高级副总裁。在Coventry任职期间,他负责金融规划和分析、投资者关系、并购、资本市场、风险、房地产和采购。他于Deloitte & Touche LLP开始自己的职业生涯,担任5年的审计员和顾问,服务的客户包括管理医疗行业。Asher持有the University of Florida会计学士学位;the University of Central Florida税收理学硕士学位。


Andrew L. Asher,has served as Centene Corporation Executive Vice President, Chief Financial Officer since May 2021. From January 2020 to May 2021, he served as Executive Vice President, Specialty. Prior to joining Centene, he served as the Chief Financial Officer of WellCare from November 2014 to January 2020.
Andrew L. Asher自2014年11月起担任公司高级副总裁和首席财务官。他于2014年8月加入WellCare高级副总裁。他领导公司的财务活动,包括财务和绩效管理、资本战略和规划、会计、精算、医疗经济学、投资管理、企业发展和投资者关系。加入WellCare之前,Asher曾担任Aetna当地和区域业务首席财务官,自2013年5月起担任,当时正值他的前任雇主公司Coventry Health Care被Aetna收购。Asher在Coventry待了15年,最近的职位是担任企业金融高级副总裁。在Coventry任职期间,他负责金融规划和分析、投资者关系、并购、资本市场、风险、房地产和采购。他于Deloitte & Touche LLP开始自己的职业生涯,担任5年的审计员和顾问,服务的客户包括管理医疗行业。Asher持有the University of Florida会计学士学位;the University of Central Florida税收理学硕士学位。
Andrew L. Asher,has served as Centene Corporation Executive Vice President, Chief Financial Officer since May 2021. From January 2020 to May 2021, he served as Executive Vice President, Specialty. Prior to joining Centene, he served as the Chief Financial Officer of WellCare from November 2014 to January 2020.
Christopher A. Koster

Christopher A. Koster自2017年以来一直担任公司服务高级副总裁。在加入Centene之前,Koster先生担任了密苏里州总检察长八年。


Christopher A. Koster,has served as Centene Corporation Executive Vice President, Secretary and General Counsel since December 2021. From February 2020 to December 2021, he served as Senior Vice President, Secretary and General Counsel. From February 2017 to February 2020, he served as Senior Vice President, Corporate Services. Prior to joining Centene, Mr. Koster served as Missouri Attorney General for eight years.
Christopher A. Koster自2017年以来一直担任公司服务高级副总裁。在加入Centene之前,Koster先生担任了密苏里州总检察长八年。
Christopher A. Koster,has served as Centene Corporation Executive Vice President, Secretary and General Counsel since December 2021. From February 2020 to December 2021, he served as Senior Vice President, Secretary and General Counsel. From February 2017 to February 2020, he served as Senior Vice President, Corporate Services. Prior to joining Centene, Mr. Koster served as Missouri Attorney General for eight years.
Katie N. Casso

Katie N. Casso自2021年4月起担任公司高级副总裁、公司总监和首席会计官。从2016年1月至2021年3月,她担任副总裁、助理总监。


Katie N. Casso,has served as Centene Corporation Senior Vice President, Corporate Controller and Chief Accounting Officer since April 2021. From January 2016 to March 2021, she served as Vice President, Assistant Controller.
Katie N. Casso自2021年4月起担任公司高级副总裁、公司总监和首席会计官。从2016年1月至2021年3月,她担任副总裁、助理总监。
Katie N. Casso,has served as Centene Corporation Senior Vice President, Corporate Controller and Chief Accounting Officer since April 2021. From January 2016 to March 2021, she served as Vice President, Assistant Controller.
Kenneth J. Fasola

Kenneth J. Fasola先生自2022年12月起担任Centene Corporation总裁。2022年1月至2022年12月,他担任医疗保健企业执行副总裁。Fasola先生于2022年1月收购Magellan Health后加入Centene,自2019年11月起担任首席执行官。2019年4月至2019年11月,他在联合医疗集团担任辅助和个人健康服务首席增长官。2010年10月至2019年4月,他担任HealthMarkets公司董事长、总裁兼首席执行官。


Kenneth J. Fasola,has served as Centene Corporation President since December 2022. From January 2022 to December 2022, he served as Executive Vice President, Health Care Enterprises. Mr. Fasola joined Centene upon the acquisition of Magellan Health in January 2022, where he served as the Chief Executive Officer since November 2019. From April 2019 to November 2019, he served as Chief Growth Officer of Ancillary and Individual Health Services at United Healthcare. From October 2010 to April 2019, he served as Chairman, President and Chief Executive Officer of HealthMarkets, Inc.
Kenneth J. Fasola先生自2022年12月起担任Centene Corporation总裁。2022年1月至2022年12月,他担任医疗保健企业执行副总裁。Fasola先生于2022年1月收购Magellan Health后加入Centene,自2019年11月起担任首席执行官。2019年4月至2019年11月,他在联合医疗集团担任辅助和个人健康服务首席增长官。2010年10月至2019年4月,他担任HealthMarkets公司董事长、总裁兼首席执行官。
Kenneth J. Fasola,has served as Centene Corporation President since December 2022. From January 2022 to December 2022, he served as Executive Vice President, Health Care Enterprises. Mr. Fasola joined Centene upon the acquisition of Magellan Health in January 2022, where he served as the Chief Executive Officer since November 2019. From April 2019 to November 2019, he served as Chief Growth Officer of Ancillary and Individual Health Services at United Healthcare. From October 2010 to April 2019, he served as Chairman, President and Chief Executive Officer of HealthMarkets, Inc.
Susan Smith

Susan Smith自2023年6月5日起成为Centene Corporation的雇员。在此之前,她在Humana Inc.工作了19年,先后担任了不断增加职责的职位,最终成为临床、质量和企业解决方案总监的高级副总裁(SVP),负责质量管理、临床战略、分析和产品开发、临床运营、风险调整和经验转型。在此之前,Smith女士担任过临床解决方案的高级副总裁和医疗保险的高级副总裁。她在Humana的其他职位包括医疗质量报告和改进的高级副总裁以及风险调整的副总裁。Smith女士拥有路易斯维尔大学Speed科学学院化学工程学士和化学工程硕士学位。


Susan Smith,has been an employee of the Company since June 5, 2023.Prior to that, she served in roles of increasing responsibility for 19 years at Humana Inc., ultimately as Senior Vice President (SVP) of Clinical, Quality and Enterprise Solutions President, where she had oversight of quality;clinical strategy, analytics and product development;clinical operations;risk adjustment;and experience transformation.Prior to that, Ms. Smith served as SVP of Clinical Solutions and SVP of Medicare.Her other roles at Humana included SVP of Healthcare Quality Reporting and Improvement and Vice President of Risk Adjustment.Ms. Smith holds a Bachelor of Science in Chemical Engineering and a Master of Engineering in Chemical Engineering – both from the University of Louisville Speed Scientific School.
Susan Smith自2023年6月5日起成为Centene Corporation的雇员。在此之前,她在Humana Inc.工作了19年,先后担任了不断增加职责的职位,最终成为临床、质量和企业解决方案总监的高级副总裁(SVP),负责质量管理、临床战略、分析和产品开发、临床运营、风险调整和经验转型。在此之前,Smith女士担任过临床解决方案的高级副总裁和医疗保险的高级副总裁。她在Humana的其他职位包括医疗质量报告和改进的高级副总裁以及风险调整的副总裁。Smith女士拥有路易斯维尔大学Speed科学学院化学工程学士和化学工程硕士学位。
Susan Smith,has been an employee of the Company since June 5, 2023.Prior to that, she served in roles of increasing responsibility for 19 years at Humana Inc., ultimately as Senior Vice President (SVP) of Clinical, Quality and Enterprise Solutions President, where she had oversight of quality;clinical strategy, analytics and product development;clinical operations;risk adjustment;and experience transformation.Prior to that, Ms. Smith served as SVP of Clinical Solutions and SVP of Medicare.Her other roles at Humana included SVP of Healthcare Quality Reporting and Improvement and Vice President of Risk Adjustment.Ms. Smith holds a Bachelor of Science in Chemical Engineering and a Master of Engineering in Chemical Engineering – both from the University of Louisville Speed Scientific School.